1. Home
  2. NXPL vs GRCE Comparison

NXPL vs GRCE Comparison

Compare NXPL & GRCE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • NXPL
  • GRCE
  • Stock Information
  • Founded
  • NXPL 1997
  • GRCE 2002
  • Country
  • NXPL United States
  • GRCE United States
  • Employees
  • NXPL N/A
  • GRCE N/A
  • Industry
  • NXPL Telecommunications Equipment
  • GRCE
  • Sector
  • NXPL Telecommunications
  • GRCE
  • Exchange
  • NXPL Nasdaq
  • GRCE NYSE
  • Market Cap
  • NXPL 32.5M
  • GRCE 35.6M
  • IPO Year
  • NXPL N/A
  • GRCE N/A
  • Fundamental
  • Price
  • NXPL $1.02
  • GRCE $3.55
  • Analyst Decision
  • NXPL
  • GRCE
  • Analyst Count
  • NXPL 0
  • GRCE 0
  • Target Price
  • NXPL N/A
  • GRCE N/A
  • AVG Volume (30 Days)
  • NXPL 123.4K
  • GRCE 129.2K
  • Earning Date
  • NXPL 11-14-2024
  • GRCE 02-21-2025
  • Dividend Yield
  • NXPL N/A
  • GRCE N/A
  • EPS Growth
  • NXPL N/A
  • GRCE N/A
  • EPS
  • NXPL N/A
  • GRCE N/A
  • Revenue
  • NXPL $66,482,000.00
  • GRCE N/A
  • Revenue This Year
  • NXPL N/A
  • GRCE N/A
  • Revenue Next Year
  • NXPL N/A
  • GRCE N/A
  • P/E Ratio
  • NXPL N/A
  • GRCE N/A
  • Revenue Growth
  • NXPL 179.89
  • GRCE N/A
  • 52 Week Low
  • NXPL $0.71
  • GRCE $2.13
  • 52 Week High
  • NXPL $2.68
  • GRCE $4.97
  • Technical
  • Relative Strength Index (RSI)
  • NXPL 45.39
  • GRCE N/A
  • Support Level
  • NXPL $0.89
  • GRCE N/A
  • Resistance Level
  • NXPL $1.08
  • GRCE N/A
  • Average True Range (ATR)
  • NXPL 0.10
  • GRCE 0.00
  • MACD
  • NXPL -0.01
  • GRCE 0.00
  • Stochastic Oscillator
  • NXPL 28.26
  • GRCE 0.00

About NXPL NextPlat Corp

NextPlat Corp is a global e-commerce and healthcare company. Its e-commerce venues form an effective global network serving thousands of consumers, enterprises, and governments. Its healthcare business is focused on improving the lives of patients with complex chronic diseases through patient and provider engagement and their partnerships with payors, pharmaceutical manufacturers, and distributors, offering a broad range of solutions to address the dispensing, delivery, dosing, and reimbursement of clinically intensive, high-cost drugs. The company operate in two segments: e-Commerce Business and Healthcare Business.

About GRCE GRACE THERAPEUTICS INC

Grace Therapeutics Inc is a late-stage specialty pharma company with drug delivery technologies and drug candidates addressing rare and orphan diseases. The company's lead drug candidate, GTx-104, is a novel injectable formulation of nimodipine for the treatment of a rare disease, aneurysmal subarachnoid hemorrhage.

Share on Social Networks: